Future challenges for health economics and health technology assessment of biological drugs

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Health Economics

• Publication date

  2010-04-18

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1007/s10198-010-0246-2PMID 20401677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The disease burden of colorectal cancer in Hungary

  2009cited by this paper
• History of health technology assessment in Hungary

  2009cited by this paper
• CEE countries: data availability and methodological issues.

  2009cited by this paper
• Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature.

  2009cited by this paper
• The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments

  2007cited by this paper
• The burden of rheumatoid arthritis and access to treatment: health burden and costs

  2007cited by this paper
• Time for a common standard for cost-effectiveness in Europe?

  2006cited by this paper
• Health technology assessment and its influence on health-care priority setting

  2004cited by this paper
• Issues for countries considering introducing the “fourth hurdle”: The case of Hungary

  2004cited by this paper

• Five-year survival and costs of care in metastatic colorectal cancer: conventional versus monoclonal antibody-based treatment protocols

  2015cites this paper
• Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis

  2014cites this paper
• [Analysis of health insurance data on home nursing care in Hungary].

  2014cites this paper
• Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma.

  2014cites this paper
• Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market

  2014cites this paper
• Health insurance data analysis on home nursing care in Hungary

  2014cites this paper
• Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries

  2013cites this paper
• Biomarkers: improving the cost‐effectiveness of biological drugs for autoimmune disorders

  2011influential citation
• Challenges and changes in the Polish healthcare system

  2011cites this paper
• The disease burden of colorectal cancer in Hungary

  2009cites this paper